ロード中...
Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19
We read with interest the article by Patel et al. on the identification of potential inhibitors of coronavirus hemagglutinin-esterase. The authors considered hemagglutinin-esterase as a glycoprotein of SARS-CoV-2 and selected hemagglutinin-esterase as a target to identify potential inhibitors using...
保存先:
| 出版年: | Mol Divers |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8267763/ https://ncbi.nlm.nih.gov/pubmed/34241772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11030-021-10272-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|